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Pharmaceutical care plays a crucial role in reducing mortal-
ity and morbidities of the patients. A hospital based quasi-
experimental study was conducted with elderly patients with
type 2 diabetes who attended at the diabetes clinic of No.(2)
Military Hospital (500-Bedded) in Myanmar from April 2013 to
February 2014.The aim of this study was to evaluate the effect
of pharmaceutical care in elderly patients with type 2 diabe-
tes mellitus. A total of 52 respondents enrolled in this study.
The clinical outcomes and quality of life of patients before and
eight months after intervention were assessed. Pharmaceuti-
cal care programwas implemented as intervention. Of the total
number of respondents, 52 drug related problems were iden-
tified. Biomedical measurements and quality of life scores of
respondents were presented as the comparison between pre
and post intervention measurements. In order to present com-
parative analysis of mean scores of outcome variables
(biomedical measurements, quality of life) before and after in-
tervention, paired t tests were used. According to results,
capillary blood glucose, blood pressure, body mass index and
waist circumference were significantly different (p < 0.05). Post-
intervention mean of quality of life scores were significantly
higher than that of pre-intervention mean scores at p level of
0.000. These findings indicated that pharmaceutical care in-
tervention could promote clinical outcomes and quality of life
of elderly patients with type 2 diabetes mellitus. Hence, it is
recommended that a better designed pharmaceutical care
program and organizational structure of clinical pharmacy
should be developed in hospitals.
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